MedTrace Logo

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.

NCT03184519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2020-08-13

Study results available
· View outcomes & findings →

Summary

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Conditions

  • Pregnancy Test

Interventions

DIAGNOSTIC_TEST

Pregnancy test

Instead of one blood sample, patients will have three blood analyses to predict pregnancy earlier after the embryo transfer.

Sponsors & Collaborators

  • Instituto Valenciano de Infertilidad, IVI VALENCIA

    lead OTHER

Principal Investigators

  • Ernesto Bosch, MDPhD · IVIRMA VALENCIA

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2018-08-10
Completion
2018-08-10

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184519 on ClinicalTrials.gov